Kathy Miller

  • 14762 Citations
  • 52 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

2020

Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial

Johns, S. A., Stutz, P. V., Talib, T. L., Cohee, A. A., Beck-Coon, K. A., Brown, L. F., Wilhelm, L. R., Monahan, P. O., LaPradd, M. L., Champion, V. L., Miller, K. D. & Giesler, R. B., Jan 1 2020, In : Cancer. 126, 1, p. 211-218 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection among Women with Dense Breasts Undergoing Screening

Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., Nicholson, M. H., Ward, R. C., Holt, J., Prather, A., Miller, K. D., Schnall, M. D. & Kuhl, C. K., Feb 25 2020, In : JAMA - Journal of the American Medical Association. 323, 8, p. 746-756 11 p.

Research output: Contribution to journalArticle

4 Scopus citations
2019

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma

Mayer, E. L., Demichele, A., Rugo, H. S., Miller, K., Waks, A. G., Come, S. E., Mulvey, T., Jeselsohn, R., Overmoyer, B., Guo, H., Barry, W. T., Huang Bartlett, C., Koehler, M., Winer, E. P. & Burstein, H. J., Sep 1 2019, In : Annals of Oncology. 30, 9, p. 1514-1520 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment

Lehman, C. D., Gatsonis, C., Romanoff, J., Khan, S. A., Carlos, R., Solin, L. J., Badve, S., McCaskill-Stevens, W., Corsetti, R. L., Rahbar, H., Spell, D. W., Blankstein, K. B., Han, L. K., Sabol, J. L., Bumberry, J. R., Gareen, I., Snyder, B. S., Wagner, L. I., Miller, K. D., Sparano, J. A. & 1 others, Comstock, C., Jul 2019, In : JAMA Oncology. 5, 7, p. 1036-1042 7 p.

Research output: Contribution to journalArticle

4 Scopus citations

Dual TGFb/BMP pathway inhibition enables expansion and characterization of multiple epithelial cell types of the normal and cancerous breast

Prasad, M., Kumar, B., Bhat-Nakshatri, P., Anjanappa, M., Sandusky, G., Miller, K. D., Storniolo, A. M. & Nakshatri, H., Jul 1 2019, In : Molecular Cancer Research. 17, 7, p. 1556-1570 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off

Upshaw, J. N., Ruthazer, R., Miller, K. D., Parsons, S. K., Erban, J. K., O'Neill, A. M., Demissei, B., Sledge, G., Wagner, L., Ky, B. & Kent, D. M., Aug 2019, In : Clinical breast cancer. 19, 4, p. 259-267.e1

Research output: Contribution to journalArticle

2 Scopus citations

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 mediates antiestrogen resistance in human breast cancer cells

Pulliam, N., Tang, J., Wang, W., Fang, F., Sood, R., O’Hagan, H. M., Miller, K. D., Clarke, R. & Nephew, K. P., Jan 1 2019, In : Cancers. 11, 1, 43.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

Hancock, B. A., Chen, Y. H., Solzak, J. P., Ahmad, M. N., Wedge, D. C., Brinza, D., Scafe, C., Veitch, J., Gottimukkala, R., Short, W., Atale, R. V., Ivan, M., Badve, S. S., Schneider, B. P., Lu, X., Miller, K. D. & Radovich, M., Aug 5 2019, In : Breast Cancer Research. 21, 1, 87.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2018

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

Mosher, C. E., Secinti, E., Li, R., Hirsh, A. T., Bricker, J., Miller, K. D., Schneider, B., Storniolo, A. M., Mina, L., Newton, E. V., Champion, V. L. & Johns, S. A., Jun 1 2018, In : Supportive Care in Cancer. 26, 6, p. 1993-2004 12 p.

Research output: Contribution to journalArticle

13 Scopus citations

An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations

Pulliam, N., Fang, F., Ozes, A. R., Tang, J., Adewuyi, A., Keer, H., Lyons, J., Baylin, S. B., Matei, D., Nakshatri, H., Rassool, F. V., Miller, K. D. & Nephew, K. P., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3163-3175 13 p.

Research output: Contribution to journalArticle

21 Scopus citations

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B. P., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K. D., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

9 Scopus citations

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Sparano, J., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W. & Miller, K. D., Dec 2018, In : JAMA Oncology. 4, 12, p. 1700-1706 7 p.

Research output: Contribution to journalArticle

35 Scopus citations

A system for detecting high impact-low frequency mutations in primary tumors and metastases

Anjanappa, M., Hao, Y., Simpson, E. R., Bhat-Nakshatri, P., Nelson, J. B., Tersey, S. A., Mirmira, R. G., Cohen-Gadol, A. A., Saadatzadeh, M. R., Li, L., Fang, F., Nephew, K. P., Miller, K. D., Liu, Y. & Nakshatri, H., Jan 11 2018, In : Oncogene. 37, 2, p. 185-196 12 p.

Research output: Contribution to journalArticle

11 Scopus citations

Double-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (E5103)

Miller, K. D., O'Neill, A., Gradishar, W., Hobday, T. J., Goldstein, L. J., Mayer, I. A., Bloom, S., Brufsky, A. M., Tevaarwerk, A. J., Sparano, J. A., Le-Lindqwister, N. A., Hendricks, C. B., Northfelt, D. W., Dang, C. T. & Sledge, G. W., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2621-2629 9 p.

Research output: Contribution to journalArticle

9 Scopus citations

E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer

Yeruva, S. L. H., Zhao, F., Miller, K. D., Tevaarwerk, A. J., Wagner, L. I., Gray, R. J., Sparano, J. A. & Connolly, R. M., Dec 1 2018, In : npj Breast Cancer. 4, 1, 4.

Research output: Contribution to journalReview article

18 Scopus citations

Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer

Traina, T. A., Miller, K., Yardley, D. A., Eakle, J., Schwartzberg, L. S., O'Shaughnessy, J., Gradishar, W., Schmid, P., Winer, E., Kelly, C., Nanda, R., Gucalp, A., Awada, A., Garcia-Estevez, L., Trudeau, M. E., Steinberg, J., Uppal, H., Tudor, I. C., Peterson, A. & Cortes, J., Jan 1 2018, In : Journal of Clinical Oncology. 36, 9, p. 884-890 7 p.

Research output: Contribution to journalArticle

86 Scopus citations

Factors underlying metastatic breast cancer patients' perceptions of symptom importance: a qualitative analysis

Mosher, C. E., Daily, S., Tometich, D., Matthias, M. S., Outcalt, S. D., Hirsh, A., Johns, S. A., Rand, K., Schneider, B., Mina, L., Storniolo, A. M., Newton, E. & Miller, K., Jan 2018, In : European Journal of Cancer Care. 27, 1, e12540.

Research output: Contribution to journalArticle

4 Scopus citations

Impact of primary breast cancer therapy on energetic capacity and body composition

Ballinger, T. J., Reddy, A., Althouse, S. K., Nelson, E. M., Miller, K. D. & Sledge, J. S., Nov 1 2018, In : Breast Cancer Research and Treatment. 172, 2, p. 445-452 8 p.

Research output: Contribution to journalArticle

Metastatic breast cancer patients’ expectations and priorities for symptom improvement

Tometich, D. B., Mosher, C. E., Hirsh, A. T., Rand, K. L., Johns, S. A., Matthias, M. S., Outcalt, S. D., Schneider, B. P., Mina, L., Storniolo, A. M. V., Newton, E. V. & Miller, K. D., Nov 1 2018, In : Supportive Care in Cancer. 26, 11, p. 3781-3788 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

Kornblum, N., Zhao, F., Manola, J., Klein, P., Ramaswamy, B., Brufsky, A., Stella, P. J., Burnette, B., Telli, M., Makower, D. F., Cheema, P., Truica, C. I., Wolff, A. C., Soori, G. S., Haley, B., Wassenaar, T. R., Goldstein, L. J., Miller, K. D. & Sparano, J. A., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1556-1563 8 p.

Research output: Contribution to journalArticle

32 Scopus citations

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

Munster, P., Krop, I. E., LoRusso, P., Ma, C., Siegel, B. A., Shields, A. F., Molnár, I., Wickham, T. J., Reynolds, J., Campbell, K., Hendriks, B. S., Adiwijaya, B. S., Geretti, E., Moyo, V. & Miller, K. D., Oct 30 2018, In : British Journal of Cancer. 119, 9, p. 1086-1093 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana

Obeng-Gyasi, S., Timsina, L., Miller, K. D., Ludwig, K. K., Fisher, C. S. & Haggstrom, D. A., Dec 2018, In : Surgery (United States). 164, 6, p. 1366-1371 6 p.

Research output: Contribution to journalArticle

3 Scopus citations
2017

64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer

Lee, H., Shields, A. F., Siegel, B. A., Miller, K. D., Krop, I., Ma, C. X., Lorusso, P. M., Munster, P. N., Campbell, K., Gaddy, D. F., Leonard, S. C., Geretti, E., Blocker, S. J., Kirpotin, D. B., Moyo, V., Wickham, T. J. & Hendriks, B. S., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4190-4202 13 p.

Research output: Contribution to journalArticle

92 Scopus citations

Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy?

Partridge, A. H., Sepucha, K., O’Neill, A., Miller, K. D., Baker, E., Dang, C. T., Northfelt, D. W., Sledge, G. W. & Schneider, B. P., Oct 1 2017, In : Breast Cancer Research and Treatment. 165, 3, p. 545-553 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Genome-wide association study for anthracycline-induced congestive heart failure

Schneider, B. P., Shen, F., Gardner, L., Radovich, M., Li, L., Miller, K. D., Jiang, G., Lai, D., O'Neill, A., Sparano, J. A., Davidson, N. E., Cameron, D., Gradus-Pizlo, I., Mastouri, R. A., Suter, T. M., Foroud, T. & Sledge, G. W., Jan 1 2017, In : Clinical Cancer Research. 23, 1, p. 43-51 9 p.

Research output: Contribution to journalArticle

19 Scopus citations

Impact of genetic ancestry on outcomes in ECOG-ACRIN-5103

Schneider, B. P., Shen, F., Jiang, G., O'Neill, A., Radovich, M., Li, L., Gardner, L., Lai, D., Foroud, T., Sparano, J. A., Sledge, G. W. & Miller, K. D., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-9 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Chen, Y. H., Hancock, B. A., Solzak, J. P., Brinza, D., Scafe, C., Miller, K. D. & Radovich, M., Jan 1 2017, In : npj Breast Cancer. 3, 1, 24.

Research output: Contribution to journalArticle

Open Access
25 Scopus citations

Questioning our APHINITY for more

Miller, K. D., Jul 13 2017, In : New England Journal of Medicine. 377, 2, p. 186-187 2 p.

Research output: Contribution to journalEditorial

12 Scopus citations

Randomized phase II study of ramucirumab or icrucumab in combination with capecitabine in patients with previously treated locally advanced or metastatic breast cancer

Vahdat, L. T., Layman, R., Yardley, D. A., Gradishar, W., Salkeni, M. A., Joy, A. A., Garcia, A. A., Ward, P., Khatcheressian, J., Sparano, J., Rodriguez, G., Tang, S., Gao, L., Dalal, R. P., Kauh, J. & Miller, K., Mar 2017, In : Oncologist. 22, 3, p. 245-254 10 p.

Research output: Contribution to journalArticle

6 Scopus citations

Role of RPL39 in Metaplastic Breast Cancer

Dave, B., Gonzalez, D. D., Liu, Z. B., Li, X., Wong, H., Granados, S., Ezzedine, N. E., Sieglaff, D. H., Ensor, J. E., Miller, K., Radovich, M., KarinaEtrovic, A., Gross, S. S., Elemento, O., Mills, G. B., Gilcrease, M. Z. & Chang, J. C., Jun 1 2017, In : Journal of the National Cancer Institute. 109, 6

Research output: Contribution to journalArticle

21 Scopus citations

Survival benefit needed to undergo chemotherapy: Patient and physician preferences

Vaz-Luis, I., O'Neill, A., Sepucha, K., Miller, K. D., Baker, E., Dang, C. T., Northfelt, D. W., Winer, E. P., Sledge, G. W., Schneider, B. & Partridge, A. H., Aug 1 2017, In : Cancer. 123, 15, p. 2821-2828 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility

Mosher, C. E., Tometich, D. B., Hirsh, A., Rand, K. L., Johns, S. A., Matthias, M. S., Outcalt, S. D., Bricker, J., Schneider, B., Mina, L., Storniolo, A. M., Newton, E. & Miller, K., Nov 2017, In : Psycho-Oncology. 26, 11, p. 1944-1951 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
2016

Cardiac outcomes of patients receiving adjuvant weekly paclitaxel and trastuzumab for node-negative, ERBB2-positive breast cancer

Dang, C., Guo, H., Najita, J., Yardley, D., Marcom, K., Albain, K., Rugo, H., Miller, K., Ellis, M., Shapira, I., Wolff, A. C., Carey, L. A., Moy, B., Groarke, J., Moslehi, J., Krop, I., Burstein, H. J., Hudis, C., Winer, E. P. & Tolaney, S. M., Jan 2016, In : JAMA Oncology. 2, 1, p. 29-36 8 p.

Research output: Contribution to journalArticle

31 Scopus citations

Charcot-Marie-Tooth gene, SBF2, associated with taxaneinduced peripheral neuropathy in African Americans

Schneider, B. P., Lai, D., Shen, F., Jiang, G., Radovich, M., Li, L., Gardner, L., Miller, K. D., O'Neill, A., Sparano, J. A., Xue, G., Foroud, T. & Sledge, G. W., Jan 1 2016, In : Oncotarget. 7, 50, p. 82244-82253 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

HERMIONE: A randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

Miller, K., Cortes, J., Hurvitz, S. A., Krop, I. E., Tripathy, D., Verma, S., Riahi, K., Reynolds, J. G., Wickham, T. J., Molnar, I. & Yardley, D. A., Jun 3 2016, In : BMC Cancer. 16, 1, 352.

Research output: Contribution to journalArticle

55 Scopus citations

Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors

Johns, S. A., Brown, L. F., Beck-Coon, K., Talib, T. L., Monahan, P. O., Giesler, R. B., Tong, Y., Wilhelm, L., Carpenter, J. S., Von Ah, D., Wagner, C. D., de Groot, M., Schmidt, K., Monceski, D., Danh, M., Alyea, J. M., Miller, K. D. & Kroenke, K., Oct 1 2016, In : Supportive Care in Cancer. 24, 10, p. 4085-4096 12 p.

Research output: Contribution to journalArticle

34 Scopus citations

Triple negative breast cancer-review of current and emerging therapeutic strategies

Ballinger, T., Kremer, J. & Miller, K., Jan 1 2016, In : European Oncology and Haematology. 12, 2, p. 112-117 6 p.

Research output: Contribution to journalArticle

6 Scopus citations
2015
6 Scopus citations

Effect of unblinding on participants' perceptions of risk and confidence in a large double-blind clinical trial of chemotherapy for breast cancer

Partridge, A. H., Sepucha, K., O'Neill, A., Miller, K. D., Motley, C., Swaby, R. F., Schneider, B. P., Dang, C. T., Northfelt, D. W. & Sledge, G. W., Jun 1 2015, In : JAMA Oncology. 1, 3, p. 369-374 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Schneider, B. P., Li, L., Radovich, M., Shen, F., Miller, K. D., Flockhart, D. A., Jiang, G., Vance, G., Gardner, L., Vatta, M., Bai, S., Lai, D., Koller, D., Zhao, F., O'Neill, A., Smith, M. L., Railey, E., White, C., Partridge, A., Sparano, J. & 3 others, Davidson, N. E., Foroud, T. & Sledge, G. W., Nov 15 2015, In : Clinical Cancer Research. 21, 22, p. 5082-5091 10 p.

Research output: Contribution to journalArticle

56 Scopus citations

TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis

Perkins, S. M., Bales, C., Vladislav, T., Althouse, S., Miller, K. D., Sandusky, G., Badve, S. & Nakshatri, H., Aug 31 2015, In : Breast Cancer Research and Treatment. 152, 3, p. 519-531 13 p.

Research output: Contribution to journalArticle

15 Scopus citations
10 Scopus citations
2014

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

Miller, K. D., Althouse, S. K., Nabell, L., Rugo, H., Carey, L., Kimmick, G., Jones, D. R., Merino, M. J. & Steeg, P. S., Oct 14 2014, In : Breast Cancer Research and Treatment. 148, 1, p. 99-106 8 p.

Research output: Contribution to journalArticle

8 Scopus citations

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103

Ruddy, K. J., O'Neill, A., Miller, K. D., Schneider, B. P., Baker, E., Sparano, J. A., Dang, C., Northfelt, D. W., Sledge, G. W. & Partridge, A. H., Apr 2014, In : Breast Cancer Research and Treatment. 144, 3, p. 591-597 7 p.

Research output: Contribution to journalArticle

23 Scopus citations

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains

Champion, V. L., Wagner, L. I., Monahan, P. O., Daggy, J., Smith, L., Cohee, A., Ziner, K. W., Haase, J. E., Miller, K. D., Pradhan, K., Unverzagt, F. W., Cella, D., Ansari, B. & Sledge, G. W., Aug 1 2014, In : Cancer. 120, 15, p. 2237-2246 10 p.

Research output: Contribution to journalArticle

92 Scopus citations

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: Critical role for neuregulin blockade in antitumor response to combination therapy

Phillips, G. D. L., Fields, C. T., Li, G., Dowbenko, D., Schaefer, G., Miller, K., Andre, F., Burris, H. A., Albain, K. S., Harbeck, N., Dieras, V., Crivellari, D., Fang, L., Guardino, E., Olsen, S. R., Crocker, L. M. & Sliwkowski, M. X., Jan 15 2014, In : Clinical Cancer Research. 20, 2, p. 456-468 13 p.

Research output: Contribution to journalArticle

106 Scopus citations

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Schneider, B. P., Li, L., Shen, F., Miller, K. D., Radovich, M., O'Neill, A., Gray, R. J., Lane, D., Flockhart, D. A., Jiang, G., Wang, Z., Lai, D., Koller, D., Pratt, J. H., Dang, C. T., Northfelt, D., Perez, E. A., Shenkier, T., Cobleigh, M., Smith, M. L. & 7 others, Railey, E., Partridge, A., Gralow, J., Sparano, J., Davidson, N. E., Foroud, T. & Sledge, G. W., Sep 9 2014, In : British Journal of Cancer. 111, 6, p. 1241-1248 8 p.

Research output: Contribution to journalArticle

24 Scopus citations

Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer

Miller, K. D., Diéras, V., Harbeck, N., Andre, F., Mahtani, R. L., Gianni, L., Albain, K. S., Crivellari, D., Fang, L., Michelson, G., De Haas, S. L. & Burris, H. A., May 1 2014, In : Journal of Clinical Oncology. 32, 14, p. 1437-1444 8 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer

O'Shaughnessy, J., Hellerstedt, B., Schwartzberg, L., Yardley, D. A., Danso, M. A., Robert, N., Richards, P., Miller, K. D., Rugo, H. S., Carlson, R. W., Finn, R. S., Neubauer, M., Saleh, M., Specht, J. M., Charpentier, E., Garcia-Ribas, I. & Winer, E. P., Dec 1 2014, In : Journal of Clinical Oncology. 32, 34, p. 3840-3847 8 p.

Research output: Contribution to journalArticle

168 Scopus citations
2013

A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109

Mina, L. A., Yu, M., Johnson, C., Burkhardt, C., Miller, K. D. & Zon, R., Oct 1 2013, In : Investigational New Drugs. 31, 5, p. 1307-1310 4 p.

Research output: Contribution to journalArticle

23 Scopus citations